表紙
市場調査レポート

感染症診断市場:製品別(装置、試薬、サービス、ソフトウェア)、用途別(C型肝炎、AIDS、結核)、技術別(PCR、INAAT、DNAシーケンシング、ハイブリッド化)、エンドユーザー別(病院、試験所) - 動向および世界市場予測

Infectious Disease Diagnostics Market: Product (Instruments, Reagents, Services, Software), Application (Hepatitis C, AIDS, Tuberculosis), Technology (PCR, INAAT, DNA Sequencing, Hybridization), End User (Hospital, Laboratories): Global Forecast to 2019

発行 MarketsandMarkets 商品コード 322724
出版日 ページ情報 英文 210 Pages
即納可能
価格
本日の銀行送金レート: 1USD=105.42円で換算しております。
Back to Top
感染症診断市場:製品別(装置、試薬、サービス、ソフトウェア)、用途別(C型肝炎、AIDS、結核)、技術別(PCR、INAAT、DNAシーケンシング、ハイブリッド化)、エンドユーザー別(病院、試験所) - 動向および世界市場予測 Infectious Disease Diagnostics Market: Product (Instruments, Reagents, Services, Software), Application (Hepatitis C, AIDS, Tuberculosis), Technology (PCR, INAAT, DNA Sequencing, Hybridization), End User (Hospital, Laboratories): Global Forecast to 2019
出版日: 2015年01月08日 ページ情報: 英文 210 Pages
概要

感染症診断市場は2019年までにCAGR7.9%となり、181億5,620万米ドルに達すると予測されています。免疫診断や生化学的特性化などの従来の診断技術が最大セグメントですが、マイクロアレイや等温核酸増幅技術(INAAT)などが急速に成長しています。

当レポートでは、世界の感染症診断市場について調査し、製品別、用途別、技術別、エンドユーザー別の動向、地域別動向、および参入企業のプロファイルなどをまとめています。

第1章 イントロダクション

第2章 調査方法

第3章 エグゼクティブサマリー

第4章 プレミアムインサイト

第5章 市場概要

  • イントロダクション
  • 市場セグメンテーション
  • 市場動向
    • 促進因子
    • 阻害因子
    • 機会
    • 課題
    • 成功の秘訣
    • 問題点

第6章 業界概要

  • イントロダクション
  • サプライチェーン分析
  • PEST分析
  • 業界動向
  • 戦略的ベンチマーキング

第7章 製品別感染症診断市場

  • イントロダクション
  • 装置および分析装置
  • 消耗品
    • アッセイおよび試薬
  • サービスおよびソフトウェア

第8章 用途別感染症診断市場

  • イントロダクション
  • B型肝炎
  • C型肝炎
  • AIDS
  • 結核
  • クラミジアトラコマチスおよび淋菌
  • ヒトパピロマウイルス感染
  • MRSA院内感染
  • その他

第9章 技術別感染症診断市場

  • イントロダクション
  • 従来の診断技術
    • 免疫診断
    • 顕微鏡検査
    • 生化学的特性化
  • 分子診断
    • PCR
    • INAAT
    • ハイブリッド化
    • DNAシーケンシングおよび次世代シーケンシング
    • マイクロアレイ
    • その他

第10章 エンドユーザー別感染症診断市場

  • イントロダクション
  • 病院および試験所
  • 参照試験所
  • 医局ラボ
  • 学術機関(学術医療センター/研究ラボ、大学内試験所)
  • その他

第11章 地域別分析

  • イントロダクション
  • 北米
  • 欧州
  • アジア太平洋地域
  • その他

第12章 競合環境

第13章 企業プロファイル

  • Abbott Laboratories
  • Becton, Dickinson & Co.
  • Biomerieux
  • Bio-Rad Laboratories
  • Alere, Inc.
  • Thermo Fisher Scientific, Inc. ?
  • Siemens Healthcare
  • Roche Diagnostics
  • Danaher Corporation
  • Johnson and Johnson

第14章 付録

図表

目次
Product Code: MD 3088

Increasing Prevalence of Deadly Infectious Disease and Need For Highly Specific and Sensitive Technologies for Rapid Diagnosis to Drive Growth of the IDD Market

The global IDD market report is segmented by product, application, technology, end user, and region. The immunodiagnostics and polymerase chain reaction technology segments accounted for the lion's share of the global IDD market by technology, owing to growing need for advanced technologies for rapid diagnosis of infectious diseases.

On the basis of application, the IDD market is categorized into the Hepatitis B, Hepatitis C, Human Immunodeficiency Virus (HIV), Tuberculosis (TB), Chlamydia trachomatis and Neisseria gonorrhoeae (CT/NG), human papillomavirus (HPV), methicillin-resistant Staphylococcus aureus (MRSA), and others (Influenza, Ebola, Typhoid, Malaria, and Dengue, among others). Hospital-acquired MRSA infections, human papillomavirus, and AIDS are expected to be new revenue pockets in the applications market. The rising prevalence of these diseases globally is the major factor driving the growth of the aforementioned markets.

On the basis of product, the IDD market is segmented into instruments, consumables (reagents and assays), and software & services. Among products, consumables are estimated to be the fastest-growing market owing to its growing adoption in emerging infectious disease diagnostics worldwide.

On the basis of end user, the market is segmented into hospital laboratories, reference labs, physician's office labs, academics, and others (blood banks, local public health laboratories, home health agencies, nursing homes, point of care, self-testing). Hospital laboratories are expected to be the fastest-growing market in the forecast period. Owing to the complexity and highly specialized nature of diagnostic tests for infectious diseases, hospital laboratories are expected to grow at the fastest rate in the forecast period, from 2014 to 2019.

From an insight perspective, this report focuses on qualitative data, market size, and the growth of various segments and subsegments, competitive landscape, and company profiles. The qualitative data covers various levels of industry analysis, such as market dynamics (drivers, restraints, opportunities, and threats), winning imperatives, and burning issues. The report also offers market sizes and related growth of various segments in the industry. It focuses on emerging and high-growth segments of the IDD market, high-growth regions, and initiatives of respective governments. The competitive landscape covers growth strategies adopted by industry players in the last three years. The company profiles offer basic views on key players in the IDD market and their product portfolios, recent developments, and key strategies adopted. The abovementioned market research data, current market size, and forecast of future trends will help key players and new entrants to make the necessary decisions regarding product offerings, geographical focus, approaches, R&D investments for innovations in products and technologies, and levels of output, in order to remain successful.

Table of Contents

1. Introduction

  • 1.1. Objectives of the Study
  • 1.2. Market Definition
  • 1.3. Markets Covered
  • 1.4. Years Considered for the Study
  • 1.5. Currency
  • 1.6. Limitations
  • 1.7. Stakeholders

2. Research Methodology

  • 2.1. Market Size Estimation
  • 2.2. Market Crackdown and Data Triangulation
    • 2.2.1. Key Data From Secondary Sources
    • 2.2.2. Key Data From Primary Sources
      • 2.2.2.1. Key Industry Insights
    • 2.2.3. Assumptions

3. Executive Summary

4. Premium Insights

  • 4.1. Market to Grow at A Modest Rate
  • 4.2. Market, By Product
  • 4.3. Global Market, By Application
  • 4.4. Global Market, By Technique
  • 4.5. Global Market, By End User
  • 4.6. Market, By Geography
  • 4.7. Lifecycle Analysis, By Region

5. Market Overview

  • 5.1. Introduction
  • 5.2. Market Segmentation
    • 5.2.1. Market, By Product
    • 5.2.2. Market, By Application
    • 5.2.2. Market, By Technique
    • 5.2.3. Market, By End User
  • 5.3. Market Dynamics
    • 5.3.1. Drivers
      • 5.3.1.1. High Prevalence Rate of Infectious Diseases to Drive the Growth of Idd Market
      • 5.3.1.2. Slow Turnaround Time of the Current Diagnostic Cycle Has Created Demand for Rapid Diagnostic Procedures
      • 5.3.1.3. New Rapid Diagnostic Tests Hold Promise for the Improved Management and Control of Infectious Diseases
      • 5.3.1.4. Increased Funding to Propel the Idd Market
    • 5.3.2. Restraints
      • 5.3.2.1. Rising Healthcare Costs Limits the Usage of Novel Infectious Disease Diagnostic Techniques
      • 5.3.2.2. Complex Regulatory Framework to Delay Approvals of New Diagnostic Tests
    • 5.3.3. Opportunities
      • 5.3.3.1. Huge Growth Prospects in Developing Countries
      • 5.3.3.2. Advances in Research and Development for Better Diagnostic Procedures to offer New Growth Opportunities
      • 5.3.3.3. Personalized Medicine
    • 5.3.4. Challenges
      • 5.3.4.1. Dearth of Trained Professionals Restricting the Appropriate Use of New Diagnostic Tests
      • 5.3.4.2. Difficulties Regarding Reimbursement for New Diagnostic Tests May Hamper Innovation
    • 5.3.5. Winning Imperatives
      • 5.3.5.1. Shift in the Focus From Centralized Laboratories to Decentralized Point-of-Care Testing Augmenting the Growth of Idd Market
    • 5.3.6. Burning Issues
      • 5.3.6.1. Global Regulatory Environment Restricting the Clearance and Marketing of Infectious Disease Diagnostic Products

6. Industry Insights

  • 6.1. Introduction
  • 6.2. Supply Chain Analysis
    • 6.2.1. Key Influencers
  • 6.3. Pest Analysis
    • 6.3.1. Political Factors
    • 6.3.2. Economical Factors
    • 6.3.3. Social Factors
    • 6.3.4. Technological Factors
  • 6.4. Industry Insights
  • 6.5. Strategic Benchmarking
    • 6.5.1. New Product Launches

7. Infectious Disease Diagnostics Market, By Product

  • 7.1. Introduction
  • 7.2. Instruments & Analyzers
  • 7.3. Consumables
    • 7.3.1. Assays and Reagents
  • 7.4. Services & Softwares

8. Infectious Disease Diagnostics Market, By Application

  • 8.1. Introduction
  • 8.2. Hepatitis B
  • 8.3. Hepatitis C
  • 8.4. Aids
  • 8.5. Tuberculosis (TB)
  • 8.6. Chlamydia Trachomatis and Neisseria Gonorrhoeae (CT/NG)
  • 8.7. Human Papillomavirus (HPV) Infection
  • 8.8. Methicillin-Resistant Staphylococcus Aureus (MRSA) Hospital Acquired Infection
  • 8.9. Others (Influenza, Ebola, Typhoid, Malaria, Dengue)

9. Infectious Disease Diagnostics Market, By Technique

  • 9.1. Introduction
  • 9.2. Traditional Diagnostic Techniques
    • 9.2.1. Immunodiagnostics
    • 9.2.2. Microscopy
    • 9.2.3. Biochemical Characterization
  • 9.3. Molecular Diagnostics
    • 9.3.1. PCR
    • 9.3.2. INAAT
    • 9.3.3. Hybridization
    • 9.3.4. DNA Sequencing & NGS
    • 9.3.5. Microarray
    • 9.3.6. Others

10. Infectious Disease Diagnostics Market, By End User

  • 10.1. Introduction
  • 10.2. Hospitals Laboratories
  • 10.3. Reference Labs
  • 10.4. Physician office Labs
  • 10.5. Academics (Acadmic Medical Centers/Research Labs, University Labs)
  • 10.6. Others (Blood Banks, Local Public Health Laboratories, Home Health Agencies, Nursing Homes, Point of Care, Self Testing)

11. Geographic Analysis

  • 11.1. Introduction
  • 11.2. North America
    • 11.2.1. U.S.
    • 11.2.2. Canada
  • 11.3. Europe
  • 11.4. Asia-Pacific
  • 11.5. Rest of the World (ROW)

12. Competitive Landscape

  • 12.1. Overview
  • 12.2. Market Share Analysis
  • 12.3. Battle for Market Share: New Product Launches Was the Key Strategy
  • 12.4. New Product Launches
  • 12.5. Agreements, Partnerships, and Collaborations
  • 12.6. Acquisitions
  • 12.7. Expansions
  • 12.8. Other Developemnts

13. Company Profile

  • 13.1. Abbott Laboratories
    • 13.1.1. Business Overview
    • 13.1.2. Product Portfolio
    • 13.1.3. Key Strategy
    • 13.1.4. Recent Developments
  • 13.2. Becton, Dickinson & Co.
    • 13.2.1. Business Overview
    • 13.2.2. Product Portfolio
    • 13.2.3. Key Strategy
    • 13.2.4. Recent Developments
  • 13.3. Biomérieux
    • 13.3.1. Business Overview
    • 13.3.2. Product Portfolio
    • 13.3.3. Key Strategy
    • 13.3.4. Recent Developments
    • 13.3.5. SWOT Analysis
    • 13.3.6. MNM View
  • 13.4. Bio-Rad Laboratories
    • 13.4.1. Business Overview
    • 13.4.2. Products & Services
    • 13.4.3. Key Strategy
    • 13.4.4. Recent Developments
  • 13.5. Alere, Inc.
    • 13.5.1. Business Overview
    • 13.5.2. Product Portfolio
    • 13.5.3. Key Strategy
    • 13.5.4. Recent Developments
  • 13.6. Thermo Fisher Scientific, Inc.
    • 13.6.1. Products & Services
    • 13.6.2. Key Strategy
    • 13.6.3. Recent Developments
  • 13.7. Siemens Healthcare
    • 13.7.1. Business Overview
    • 13.7.2. Key Strategy
    • 13.7.3. Recent Developments
  • 13.8. Roche Diagnostics
    • 13.8.1. Business Overview
    • 13.8.2. Product Portfolio
    • 13.8.3. Key Strategy
    • 13.8.4. Recent Developments
  • 13.9. Danaher Corporation
    • 13.9.1. Business Overview
    • 13.9.2. Product Portfolio
    • 13.9.3. Key Strategy
    • 13.9.4. Recent Developments
  • 13.10. Johnson and Johnson
    • 13.10.1. Business Overview
    • 13.10.2. Product Portfolio
    • 13.10.3. Key Strategy
    • 13.10.4. Recent Developments

14. Appendix

  • 14.1. Insights of Industry Experts
  • 14.2. Discussion Guide
  • 14.3. Introducing RT: Real-Time Market Intelligence
  • 14.4. Available Customizations
  • 14.5. Related Reports

List of Tables

  • Table 1: Global Market Size, By Product, 2012-2019 ($Million)
  • Table 2: Market Size for Instruments, By Geography, 2012-2019 ($Million)
  • Table 3: North American Infectious Disease Diagnostics Market Size for Instruments, By Country, 2012-2019 ($Million)
  • Table 4: Market Size for Reagents, By Geography, 2012-2019 ($Million)
  • Table 5: North American Infectious Disease Diagnostics Market Size for Reagents, By Country, 2012-2019 ($Million)
  • Table 6: Market Size for Services and Softwares, By Geography, 2012-2019 ($Million)
  • Table 7: ROW Fluorescence Infectious Disease Diagnostics Market Size, By Country, 2012-2019 ($Million)
  • Table 8: North American Infectious Disease Diagnostics Market Size for Services and Softwares, By Country, 2012-2019 ($Million)
  • Table 9: Global Infectious Disease Diagnostics Market Size, By Technique, 2012-2019 ($Million)
  • Table 10: Global Traditional Infectious Disease Diagnostic Market Size, By Technique, 2012-2019 ($Million)
  • Table 11: Global Molecular Infectious Disease Diagnostic Market Size, By Technique, 2012-2019 ($Million)
  • Table 12: Market Size for Immunodiagnostics, By Geography, 2012-2019 ($Million)
  • Table 13: North American Infectious Disease Diagnostics Market Size for Immunodiagnostics, By Country, 2012-2019 ($Million)
  • Table 14: Market Size for Microscopy, By Geography, 2012-2019 ($Million))
  • Table 15: North American Infectious Disease Diagnostics Market Size for Microscopy, By Country, 2012-2019 ($Million)
  • Table 16: Market Size for Biochemical Characterization, By Geography, 2012-2019 ($Million)
  • Table 17: North American Infectious Disease Diagnostics Market Size for Biochemical Characterization, By Country, 2012-2019 ($Million)
  • Table 18: Market Size for PCR, By Geography, 2012-2019 ($Million)
  • Table 19: North American Infectious Disease Diagnostics Market Size for PCR, By Country, 2012-2019 ($Million)
  • Table 20: Market Size for INAAT, By Geography, 2012-2019 ($Million)
  • Table 21: North American Infectious Disease Diagnostics Market Size for INAAT, By Country, 2012-2019 ($Million)
  • Table 22: Market Size for Hybridization, By Geography, 2012-2019 ($Million)
  • Table 23: North American Infectious Disease Diagnostics Market Size for Hybridization, By Country, 2012-2019 ($Million)
  • Table 24: Market Size for DNA Sequencing & NGS, By Geography, 2012-2019 ($Million)
  • Table 26: North American Infectious Disease Diagnostics Market Size for DNA Sequencing & NGS, By Country, 2012-2019 ($Million)
  • Table 27: Market Size for Microarray, By Geography, 2012-2019 ($Million)
  • Table 28: North American Infectious Disease Diagnostics Market Size for Microarray, By Country, 2012-2019 ($Million)
  • Table 29: Market Size for Others, By Geography, 2012-2019 ($Million)
  • Table 30: North American Infectious Disease Diagnostics Market Size for Others, By Country, 2012-2019 ($Million)
  • Table 31: Global Infectious Disease Diagnostics Market Size, By Application, 2012-2019 ($Million)
  • Table 32: Market Size for Hepatitis B, By Geography, 2012-2019 ($Million)
  • Table 33: North American Infectious Disease Diagnostics Market Size for Hepatitis B, By Country, 2012-2019 ($Million)
  • Table 34: Market Size for Hepatitis C, By Geography, 2012-2019 ($Million)
  • Table 35: North American Infectious Disease Diagnostics Market Size for Hepatitis C, By Country, 2012-2019 ($Million)
  • Table 36: Market Size for Aids, By Geography, 2012-2019 ($Million)
  • Table 37: North American Infectious Disease Diagnostics Market Size for Aids, By Country, 2012-2019 ($Million)
  • Table 38: Market Size for Tuberculosis, By Geography, 2012-2019 ($Million)
  • Table 39: North American Infectious Disease Diagnostics Market Size for Tuberculosis, By Country, 2012-2019 ($Million)
  • Table 40: Market Size for CT/NG, By Geography, 2012-2019 ($Million)
  • Table 41: Market Size for HPV, By Geography, 2012-2019 ($Million)
  • Table 42: Market Size for MRSA (Hospital Acquired Infection), By Geography, 2012-2019 ($Million)
  • Table 43: Market Size for Others, By Geography, 2012-2019 ($Million)
  • Table 44: Global Market Size, By End User, 2012-2019 ($Million)
  • Table 45: North America: Electron Market Size, By Type, 2012-2019 ($Million)
  • Table 46: Hospital Laboratories Infectious Disease Diagnostics Market Size, By Region , 2012-2019 ($Million)
  • Table 47: North America Hospital Laboratories Infectious Disease Diagnostics Market Size, By Country , 2012-2019 ($Million)
  • Table 48: Reference Labs Infectious Disease Diagnostics Market Size, By Region , 2012-2019 ($Million)
  • Table 49: North America Reference Labs Infectious Disease Diagnostics Market Size, By Country , 2012-2019 ($Million)
  • Table 50: Physician office Labs Infectious Disease Diagnostics Market Size, By Region , 2012-2019 ($Million))
  • Table 51: North America Physician office Labs Infectious Disease Diagnostics Market Size, By Country , 2012-2019 ($Million)
  • Table 52: Academics Infectious Disease Diagnostics Market Size, By Region , 2012-2019 ($Million))
  • Table 53: North America Academics Infectious Disease Diagnostics Market Size, By Country , 2012-2019 ($Million)
  • Table 54: Other End Users Infectious Disease Diagnostics Market Size, By Region , 2012-2019 ($Million)
  • Table 55: North America Other End Users Infectious Disease Diagnostics Market Size, By Country , 2012-2019 ($Million)
  • Table 56: Global Infectious Disease Diagnostics Market Size, By Region, 2012-2019 ($Million)
  • Table 57: North America: Market Size, By Country, 2012-2019 ($Million)
  • Table 58: North America: Market Size, By Technique, 2012-2019 ($Million)
  • Table 59: North America: Traditional Infectious Disease Diagnostic Market Size, By Technique, 2012-2019 ($Million)
  • Table 60: North America: Molecular Infectious Disease Diagnostic Market Size, By Technique, 2012-2019 ($Million)
  • Table 61: North America: Market Size, By Product, 2012-2019 ($Million)
  • Table 62: North America: Market Size, By Application, 2012-2019 ($Million)
  • Table 63: North America: Market Size, By End User, 2012-2019 ($Million)
  • Table 64: U.S. Market Size, By Technique, 2012-2019 ($Million)
  • Table 65: U.S. Traditional Infectious Disease Diagnostic Market Size, By Technique, 2012-2019 ($Million)
  • Table 66: U.S. Molecular Infectious Disease Diagnostic Market Size, By Technique, 2012-2019 ($Million)
  • Table 67: U.S. Market Size, By Product, 2012-2019 ($Million)
  • Table 68: U.S. Market Size, By Application, 2012-2019 ($Million)
  • Table 69: U.S. Market Size, By End User, 2012-2019 ($Million)
  • Table 70: Canada: Market Size, By Technique, 2012-2019 ($Million)
  • Table 71: Canada: Traditional Infectious Disease Diagnostic Market Size, By Technique, 2012-2019 ($Million)
  • Table 72: Canada: Molecular Infectious Disease Diagnostic Market Size, By Technique, 2012-2019 ($Million)
  • Table 73: Canada: Market Size, By Product, 2012-2019 ($Million)
  • Table 74: Canada: Market Size, By Application, 2012-2019 ($Million)
  • Table 75: Canada: Market Size, By End User, 2012-2019 ($Million)
  • Table 76: Europe: Market Size, By Technology, 2012-2019 ($Million)
  • Table 77: Europe: Traditional Infectious Disease Diagnostic Market Size, By Technique, 2012-2019 ($Million)
  • Table 78: Europe: Molecular Infectious Disease Diagnostic Market Size, By Technique, 2012-2019 ($Million)
  • Table 79: Europe: Market Size, By Application, 2012-2019 ($Million)
  • Table 80: Europe: Market Size, By End User, 2012-2019 ($Million)
  • Table 81: Asia-Pacific: Market Size, By Technique, 2012-2019 ($Million)
  • Table 82: Asia-Pacific: Traditional Infectious Disease Diagnostic Market Size, By Technique, 2012-2019 ($Million)
  • Table 83: Asia-Pacific: Molecular Infectious Disease Diagnostic Market Size, By Technique, 2012-2019 ($Million)
  • Table 84: Asia-Pacific: Market Size, By Product, 2012-2019 ($Million)
  • Table 85: Asia-Pacific: Market Size, By Application, 2012-2019 ($Million)
  • Table 86: Asia-Pacific: Market Size, By End User, 2012-2019 ($Million)
  • Table 87: ROW: Market Size, By Technique, 2012-2019 ($Million)
  • Table 88: ROW: Traditional Infectious Disease Diagnostic Market Size, By Technique, 2012-2019 ($Million)
  • Table 89: ROW: Molecular Infectious Disease Diagnostic Market Size, By Technique, 2012-2019 ($Million)
  • Table 90: ROW: Market Size, By Product, 2012-2019 ($Million)
  • Table 91: ROW: Market Size, By Application, 2012-2019 ($Million)
  • Table 92: ROW: Market Size, By End User, 2012-2019 ($Million)
  • Table 93: New Product Launches, 2011-2014
  • Table 94: Agreements, Partnerships, and Collaborations, 2011-2014
  • Table 95: Acquisitions, 2011-2014
  • Table 96: Expansions 2011-2014
  • Table 97: Other Developments, 2011-2014

List of Figures

  • Figure 1: Research Methodology
  • Figure 2: Market Size Estimation
  • Figure 3: Break Down of Primary Interviews: By Company Type, Designation, and Region
  • Figure 4: Market Snapshot (2014 Vs. 2019)
  • Figure 5: Global Market, By Application, 2014
  • Figure 6: Hospital Laboratories Are the Major End Users of the Market
  • Figure 7: Geographical Snapshot, 2014
  • Figure 8: New Product Launch is the Dominant Strategy Among the Market Players
  • Figure 9: Technological Advancements and Favorable Government Funding Are Important Growth Drivers
  • Figure 10: Consumables to Account for the Largest Share in Market
  • Figure 11: Asia-Pacific to Grow at the Highest Rate During the forecast Period
  • Figure 12: Hepatitis B Segment to Dominate the Infectious Disease Diagnostics Applications Market in 2014
  • Figure 13: Hospital Laboratories Are the Major End Users of the Market
  • Figure 14: Asia-Pacific Market Showcases Lucrative Growth Opportunities
  • Figure 15: Market Segmentation, By Product
  • Figure 16: Market Segmentation, By Application
  • Figure 17: Market Segmentation, By End User
  • Figure 18: Favorable Government & Corporate Funding to Boost Market Growth
  • Figure 19: Supply Chain Analysis
  • Figure 20: Development of POC Diagnostic Techniques is the Leading Trend Among Key Players
  • Figure 21: Market Players Adopted the Organic Growth Strategy of New Product Launches
  • Figure 22: Traditional Diagnostic Techniques Accounts for the Largest Share of the Overall Market in 2014
  • Figure 23: Infectious Disease Immunodiagnostics Segment Dominates the Traditional Diagnostic Techniques Market
  • Figure 24: Companies Adopted Product Innovation As Their Key Growth Strategy Over the Last Three Years
  • Figure 25: Global Market Share, By Key Player, 2013
  • Figure 26: Abbott Laboratories: Company Snapshot
  • Figure 27: Becton, Dickinson & Co.: Company Snapshot
  • Figure 28: Biomérieux: Company Snapshot
  • Figure 29: Bio-Rad Laboratories: Company Snapshot
  • Figure 30: Alere, Inc.: Company Snapshot
  • Figure 31: Thermo Fisher Scientific, Inc: Company Snapshot
  • Figure 32: Siemens Healthcare: Company Snapshot
  • Figure 33: Roche Diagnostics.: Company Snapshot
  • Figure 34: Danaher Corporation: Company Snapshot
  • Figure 35: Johnson and Johnson: Company Snapshot
Back to Top